Evaluation of efficiency of mesenteric approach during pancreaticoduodenectomy for pancreatic cancer
Not Applicable
- Conditions
- Patients with pancreatic ductal adenocarcinoma
- Registration Number
- JPRN-UMIN000026220
- Lead Sponsor
- Second Department of Surgery, Wakayama Medical University
- Brief Summary
Mesenteric approach could reduce intraoperative blood loss volume in both resectable and borderline resectable (BR) PDAC during pancreaticoduodenectomy (PD). In resectable PDAC, mesenteric approach could increase R0 rate and improve the overall survival (OS), however, in BR PDAC, could not do them. Therefore, resectable PDAC has oncological benefits of mesenteric approach, however, only surgical method might not give the oncological benefit fo BR PDAC might.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 237
Inclusion Criteria
Not provided
Exclusion Criteria
patients without pathological diagnosis of pancreatic ductal adenocarcinoma
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood loss volume, R0 rate
- Secondary Outcome Measures
Name Time Method operative time, recurrence rate, overall survival, disease free survival